Pim kinases mediate viability signals downstream of the tyrosine kinase Oncogenes BCR-ABL and FLT3-ITD.

被引：0
|
作者：
Sattler, M [1 ]
Balbendreier, E [1 ]
Chu, SC [1 ]
Gramlich, JL [1 ]
Podar, K [1 ]
Griffin, JD [1 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
557
引用
收藏
页码：161A / 161A
页数：1
相关论文
共 44 条
  • [1] Protein kinase CK2α is a target for the Abl and Bcr-Abl tyrosine kinases
    Hériché, JK
    Chambaz, EM
    ONCOGENE, 1998, 17 (01) : 13 - 18
  • [2] Identification of common target genes of the BCR/ABL and FLT3-ITD tyrosine kinases by microarray analysis
    Banerji, L
    Scheijen, B
    Griffffin, JD
    BLOOD, 2004, 104 (11) : 966A - 966A
  • [3] Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia
    Green, Alexa S.
    Maciel, Thiago T.
    Hospital, Marie-Anne
    Yin, Chae
    Mazed, Fetta
    Townsend, Elizabeth C.
    Pilorge, Sylvain
    Lambert, Mireille
    Paubelle, Etienne
    Jacquel, Arnaud
    Zylbersztejn, Florence
    Decroocq, Justine
    Poulain, Laury
    Sujobert, Pierre
    Jacque, Nathalie
    Adam, Kevin
    So, Jason C. C.
    Kosmider, Olivier
    Auberger, Patrick
    Hermine, Olivier
    Weinstock, David M.
    Lacombe, Catherine
    Mayeux, Patrick
    Vanasse, Gary J.
    Leung, Anskar Y.
    Moura, Ivan C.
    Bouscary, Didier
    Tamburini, Jerome
    SCIENCE ADVANCES, 2015, 1 (08):
  • [4] Activated Src kinases downstream of BCR-ABL and Flt3 induces proteasomal degradation of SHIP1 by phosphorylation of tyrosine 1021
    Ehm, Patrick
    Bettin, Bettina
    Juecker, Manfred
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2023, 1870 (05):
  • [5] Critical role for Pim kinase-phosphorylated eIF4B in cellular transformation by v-Abl and Bcr-Abl oncogenes
    Yang, J.
    Chen, K.
    Wang, J.
    Guo, G.
    Chen, J.
    MOLECULAR BIOLOGY OF THE CELL, 2012, 23
  • [6] The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases
    Tatton, L
    Morley, GM
    Chopra, R
    Khwaja, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (07) : 4847 - 4853
  • [7] Design, in silico Evaluation, and Determination of Antitumor Activity of Potential Inhibitors Against Protein Kinases: Application to BCR-ABL Tyrosine Kinase
    Koroleva, Elena V.
    Ermolinskaya, Anastasiya L.
    Ignatovich, Zhanna V.
    Kornoushenko, Yury V.
    Panibrat, Alesia V.
    Potkin, Vladimir I.
    Andrianov, Alexander M.
    BIOCHEMISTRY-MOSCOW, 2024, 89 (06) : 1094 - 1108
  • [8] Interleukin-3 protects Bcr-Abl-transformed hematopoietic progenitor cells from apoptosis induced by Bcr-Abl tyrosine kinase inhibitors
    JF Dorsey
    JM Cunnick
    R Lanehart
    M Huang
    AJ Kraker
    KN Bhalla
    R Jove
    J Wu
    Leukemia, 2002, 16 : 1589 - 1595
  • [9] Interleukin-3 protects Bcr-Abl-transformed hematopoietic progenitor cells from apoptosis induced by Bcr-Abl tyrosine kinase inhibitors
    Dorsey, JF
    Cunnick, JM
    Lanehart, R
    Huang, M
    Kraker, AJ
    Bhalla, KN
    Jove, R
    Wu, J
    LEUKEMIA, 2002, 16 (09) : 1589 - 1595
  • [10] The interaction of the Bcr-Abl tyrosine kinase with the Src-kinase Hck is mediated by at least three binding regions in Bcr-Abl and by the Sh3/Sh2 domains of Hck.
    Stanglmaier, M
    Kleinlein, I
    Warmuth, M
    Häuslmann, K
    Hallek, M
    BLOOD, 1998, 92 (10) : 221A - 221A
12345